miR-371a-3p is the most consistent marker and exhibits >90% diagnostic sensitivity and specificity in TGCT.  However, miR-371a-3p cannot be used to diagnose GCNIS or mature teratoma.  Future efforts must technically standardize the microRNA-based methods internationally and introduce miR-371a-3p as a molecular liquid biopsy-based marker for TGCTs in the clinic.
miR-371a-3p
miR-371a-3p is the most consistent marker and exhibits >90% diagnostic sensitivity and specificity in TGCT.  However, miR-371a-3p cannot be used to diagnose GCNIS or mature teratoma.  Future efforts must technically standardize the microRNA-based methods internationally and introduce miR-371a-3p as a molecular liquid biopsy-based marker for TGCTs in the clinic.
miR-371a-3p
miR-371a-3p is the most consistent marker and exhibits >90% diagnostic sensitivity and specificity in TGCT.  However, miR-371a-3p cannot be used to diagnose GCNIS or mature teratoma.  Future efforts must technically standardize the microRNA-based methods internationally and introduce miR-371a-3p as a molecular liquid biopsy-based marker for TGCTs in the clinic.
miR-371a-3p
miR-371a-3p is the most consistent marker and exhibits >90% diagnostic sensitivity and specificity in TGCT.  However, miR-371a-3p cannot be used to diagnose GCNIS or mature teratoma.  Future efforts must technically standardize the microRNA-based methods internationally and introduce miR-371a-3p as a molecular liquid biopsy-based marker for TGCTs in the clinic.
miR-371a-3p
miR-371a-3p is the most consistent marker and exhibits >90% diagnostic sensitivity and specificity in TGCT.  However, miR-371a-3p cannot be used to diagnose GCNIS or mature teratoma.  Future efforts must technically standardize the microRNA-based methods internationally and introduce miR-371a-3p as a molecular liquid biopsy-based marker for TGCTs in the clinic.
miR-371a-3p